Alexion Pharm Inc (ALXN) Forecast, Price Target & Analyst Ratings

NASDAQ:ALXN

Current stock price

182.5
+3.05 (+1.7%)
At close:
183
+0.5 (+0.27%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Alexion Pharm Inc (ALXN).

Forecast Snapshot

Consensus Price Target

Price Target
$180.90
-0.87% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Feb 22, 2022
Period
Q2 / 2021
EPS Estimate
$3.39
Revenue Estimate
1.671B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
66.20%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$180.90
Upside
-0.87%
From current price of $182.50 to mean target of $180.90, Based on 13 analyst forecasts
Low
$167.66
Median
$178.50
High
$215.25

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for ALXN. The average price target is 180.9 null. This implies a price decrease of -0.87% is expected in the next year compared to the current price of 182.5.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ALXN Current Analyst RatingALXN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

ALXN Historical Analyst RatingsALXN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
66.20%
ALXN was analyzed by 13 analysts. The buy percentage consensus is at 66. So analysts seem to be have mildly positive about ALXN.
In the previous month the buy percentage consensus was at a similar level.
ALXN was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Feb 22, 2022
Period
Q2 / 2021
EPS Estimate
$3.39
Revenue Estimate
1.671B
Revenue Q2Q
28.70%
EPS Q2Q
9.15%
Number of Analysts
18

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

ALXN is expected to report earnings on 2/22/2022. The consensus EPS estimate for the next earnings is 3.39 null and the consensus revenue estimate is 1.67B null.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
ALXN revenue by date.ALXN revenue by date.
N/AN/A
18.57%		N/A
13.93%		N/A
15.30%		N/A
21.37%		N/A
21.57%		N/A
12.08%		N/A
7.59%		N/A
7.06%		N/A
5.74%		N/A
7.32%
EBITDA
YoY % growth
ALXN ebitda by date.ALXN ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ALXN ebit by date.ALXN ebit by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Margin
ALXN operating margin by date.ALXN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ALXN eps by date.ALXN eps by date.
5.014.73
-5.59%		5.86
23.89%		7.91
34.98%		10.53
33.12%		12.53
18.99%		N/A
9.86%		N/A
6.21%		N/A
9.91%		N/A
5.94%		N/A

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 21 Q3 / 21 Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth		3.39
9.15%		3.46
6.67%		3.41
15.23%		3.68
4.51%		3.79
11.72%		3.82
10.62%		3.91
14.72%
Revenue
Q2Q % growth		1.671B
28.70%		1.732B
19.66%		1.776B
15.23%		1.777B
10.59%		1.83B
9.54%		1.883B
8.73%		1.925B
8.39%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALXN Yearly Revenue VS EstimatesALXN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B
ALXN Yearly EPS VS EstimatesALXN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
8.65%
EPS Next 5 Year
6.32%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
8.89%
Revenue Next 5 Year
7.94%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Alexion Pharm Inc / ALXN Forecast FAQ

Can you provide the average price target for Alexion Pharm Inc stock?

13 analysts have analysed ALXN and the average price target is 180.9 null. This implies a price decrease of -0.87% is expected in the next year compared to the current price of 182.5.

When does Alexion Pharm Inc (ALXN) report earnings?

Alexion Pharm Inc (ALXN) will report earnings on 2022-02-22, before the market open.

What are the consensus estimates for ALXN stock next earnings?

The consensus EPS estimate for the next earnings of Alexion Pharm Inc (ALXN) is 3.39 null and the consensus revenue estimate is 1.67B null.

What is the expected long term growth rate for Alexion Pharm Inc (ALXN)?

The expected long term growth rate for Alexion Pharm Inc (ALXN) is 8.89%.